Dare Bioscience, Inc. (DARE) vs Lipocine Inc. (LPCN)
- Dare Bioscience, Inc. DARE 0.72 −2.70%
- Lipocine Inc. LPCN 1.56 −7.14%
Dare Bioscience, Inc. and Lipocine Inc. are both Biotechnology companies. Dare Bioscience, Inc. and Lipocine Inc. are of similar size ($14.6M and $13.9M). Dare Bioscience, Inc. grew revenue faster over the last twelve months: 7,817.5% against −63.5%. Lipocine Inc. has the higher net margin (−755.1% vs −804.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Lipocine Inc. leads on 10 and Dare Bioscience, Inc. on 5.
Valuation
Profitability
| Metric | DARE | LPCN | Biotechnology median |
|---|---|---|---|
| Gross margin | 58.84% | 100.00% | 65.16% |
| Operating margin | (813.35%) | (800.80%) | 0.00% |
| Net margin | (804.33%) | (755.11%) | 0.00% |
| Free cash flow margin | (849.36%) | (713.02%) | 0.00% |
| Return on equity | 165.29% | (60.94%) | (56.36%) |
| Return on assets | (62.16%) | (55.89%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack